UNSPSC 51261702: Abanoquil

Commodity

Code facts

NIGP codes
1

UNSPSC codes and definitions come from the UN Development Programme (managed by GS1 US), and state and local contract opportunities from the governments' procurement sites.

NIGP codes for 51261702

Definition

This classification denotes an alpha-adrenergic blocking agent with the molecular formula C22H25N3O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier F738MWY53L, chemically known as 4-quinolinamine, 2-(3,4-dihydro-6,7-dimethoxy-2(1h)-isoquinolinyl)-6,7-dimethoxy-, monomethanesulfonate but generally known as abanoquil, which bears US NIH Compound Identifier 164088. Abanoquil also appears in mesilate or mesylate form.

Read the full definition

European Medicines Agency schedules Abanoquil in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07358MIG. The term ABANOQUIL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 5, No. 3 1991, List 31). ABANOQUIL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule abanoquil under HS 29334990 and SITC 51575. As of Q4 2014, ABANOQUIL remains the US FDA Preferred Term for this commodity.

Abanoquil bears US NLM identifiers UMLS ID C0165215 and NCI Concept Code C72566. SMILES: S(=O)(=O)(O)C.O(C1CC2CCN(CC2CC1OC)C1NC2C(C(N)C1)CC(OC)C(OC)C2)C.

About UNSPSC 51261702

UNSPSC 51261702 Abanoquil is a Commodity code that in recent state and local solicitations covers the procurement of naloxone and drug deactivation systems for community health and harm-reduction initiatives. Naloxone—an opioid antagonist used to reverse overdose—and associated safe drug deactivation equipment represent the concrete products being acquired under this code. Issuing bodies include county health departments and state health agencies; Seminole County, Florida's recent procurement for naloxone and drug deactivation systems illustrates the county-level demand for these products to support community health operations. The work involves straightforward product procurement with delivery and inventory management rather than service delivery, and vendors must meet standard compliance requirements including drug-free workplace certification, E-Verify, and appropriate insurance coverage.

The code shows recent activity concentrated in Florida, where Seminole County issued an IFB on June 30, 2026 (due July 26, 2023) for 1,900 units of naloxone and 800 safe drug deactivation systems annually, with quarterly deliveries to the Seminole County Community Health Building in Sanford. Texas HHS also posted a preliminary RFI on April 3, 2026 for Therapeutic Pharmacy Initiative direct-to-manufacturer prescription capabilities, though that solicitation focuses on prescription fulfillment mechanisms rather than discrete naloxone procurement. The Seminole County opportunity is a two-year term with optional one-year renewal on a fixed-fee basis, with all shipping and delivery included in vendor pricing. Limited recent-opportunity data restricts broader geographic characterization; the code shows meaningful activity in the Southeast through the Seminole County procurement and preliminary market-intelligence gathering at the state level in Texas.

Quick answers

What is UNSPSC 51261702?

UNSPSC 51261702 is Abanoquil, a commodity in UNSPSC 51000000, Pharmaceutical Products incl. Contraceptives and Vaccines.

Which NIGP codes match UNSPSC 51261702?

UNSPSC 51261702 maps to 1 NIGP code, 26912 Autonomic Drugs.

On GovTribe

See everything under UNSPSC 51261702

  • State & local contract opportunities, awards and contract vehicles under this code
  • Contacts who buy under this code
  • Ask GovTribe AI about this code